Trabajos de Titulación - Enfermería
URI permanente para esta colección
Examinar
Examinando Trabajos de Titulación - Enfermería por Materia "ABORDAJE TERAPÉUTICO"
Mostrando 1 - 2 de 2
Resultados por página
Opciones de ordenación
- ÍtemAcceso AbiertoIntervenciones de enfermería en síndrome de colon irritable(Universidad Católica de Cuenca., 2024) Cango Rodríguez, Maby Yanina; Cobos Guallpa, Jessica Patricia; Ortiz Davalos, Nancy Gabriela; 1950192086; 0106332026Introduction: Irritable Bowel Syndrome (IBS) is one of the gastrointestinal disorders that damage the digestive system, so there is a high prevalence affecting 30% of the world population; likewise, it is a challenge to find timely treatment and diagnosis. Objective: To analyze scientific papers on Nursing Interventions in Irritable Bowel Syndrome. Methodology: A descriptive literature review was conducted through a search in databases such as SciELO, PubMed, Redalyc, and ScienceDirect. The following terms were used in a variety of languages: Irritable Bowel Syndrome, associated factors, etiology, treatment, therapy, and nursing interventions. Boolean operator such as “AND” and “OR” were also employed. Results: Studies show that the prevalence of this condition is between 10% and 15%. However, this figure varies in South America, with 21%, and Southeast Asia with 7%. In the therapeutic approach, three levels are proposed: the first is a traditional approach that will alleviate the main symptom, the second consists of the use of some psychotropic drugs and psychological therapies, and the last one involves a modification of the intestinal microbiota with diet, prebiotics, and antibiotics. Conclusion: Regarding the prevalence in Latin America, Venezuela represents 59%, with 14% in women and 5.4% in men. It is known that psychological problems, genetic factors, and unhealthy eating habits have been linked to IBS. The nursing staff provides a space for users to share concerns and fears, employing techniques such as deep breathing and progressive muscle relaxation.
- ÍtemAcceso AbiertoSíndrome antifosfolipídico(Universidad Católica de Cuenca., 2024) González Tene, Lourdes Aurora; Tinizaray Carrión , Angela Melisa; Siguenza Pacheco , Marco Antonio; 1900832948; 1950001527Antiphospholipid syndrome (APS), also known as Hughes syndrome, was first described in 1983. This disorder is characterized by mistakenly attacking normal blood proteins, causing hypercoagulability, and contributing to the formation of blood clots in veins, arteries, and organs. There are two types of APS: Primary APS (PAPS) and Secondary APS (SAPS), which is understood as secondary when it is accompanied by other diseases that affect the immune system, as in the case of systemic lupus erythematosus (SLE), rheumatoid arthritis, and Sjögren's syndrome; it is referred as primary when it occurs without any visible cause. In addition, in specific cases, it is called catastrophic APS, which generates a multiorgan failure and can cause the death of those who suffer from it. Its worldwide prevalence is estimated at 1 to 5%, which represents 40 to 50 cases per 100,000 individuals of the world population. This syndrome affects more females than males, and in pregnant women, there is a higher risk of miscarriages and stillbirths. The most commonly used treatment for this syndrome is anticoagulants; in the case of pregnant women, heparin and low-dose aspirin have been used. The factors for diagnosis include age and gender, and, in the case of a woman, to verify that the patient is not pregnant.